AdaptHealth (AHCO) Stifel 2024 Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Stifel 2024 Healthcare Conference summary
13 Jan, 2026Leadership transition and organizational focus
New CEO prioritized fixing integration issues and establishing clear governance and metrics.
Leadership team nearly finalized, with new COO and Chief Medical and Strategy Officer in place; Chief Commercial Officer announcement imminent.
Introduced segment reporting and general managers for four business segments to drive performance.
Emphasis on operational hygiene, standardization, and a five-point plan to unify the organization and pause large M&A in favor of organic growth.
Automation and AI implementation underway to streamline basic processes.
Strategic priorities and operational improvements
Focus for 2025 is on execution, patient experience, and exceptional service, with growth initiatives planned for late 2025 and 2026.
Sleep and respiratory segments performing well, with sleep representing 40% of revenue and strong patient demand.
Wellness at Home and supplies business require further improvement.
Diabetes segment identified as the most significant challenge, with internal operational issues being addressed.
Sales force expansion in diabetes did not yield expected growth; operational fixes prioritized before further sales efforts.
Segment performance and market dynamics
Sleep business up 3.5% in Q3, with over 120,000 new patients and record resupply census; two-year growth nearly 10%.
Group setups and virtual fitting have improved efficiency and patient preference.
Conversion rates under review, with process simplification and standardization underway to boost growth.
Sleep resupply team integrated with diabetes resupply to leverage best practices and drive quick operational fixes.
Latest events from AdaptHealth
- Record operational gains and exclusive payer contracts drive growth and portfolio focus.AHCO
Leerink Global Healthcare Conference 20269 Mar 2026 - Expanding market share and operational scale in sleep and respiratory care, with strong contract growth.AHCO
J.P. Morgan 2026 Global Leveraged Finance Conference3 Mar 2026 - Record patient growth and a major contract drove 2025, but a $128M impairment led to a net loss.AHCO
Q4 202524 Feb 2026 - Q2 revenue up 1.6%, net income up 39%, strong cash flow, and ongoing legal challenges.AHCO
Q2 20242 Feb 2026 - Five-point plan drives growth as respiratory and sleep outperform, while GLP-1 use rises among new CPAP patients.AHCO
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Q3 2024 returned to profitability with $22.9M net income and improved cash flow.AHCO
Q3 202416 Jan 2026 - Operational integration, segment focus, and payer partnerships drive stable, optimistic growth.AHCO
Bank of America Home Care Conference11 Jan 2026 - Reorganized into four segments, targeting modest growth and operational improvements in 2025.AHCO
Barclays 27th Annual Global Healthcare Conference 202526 Dec 2025 - Strong sleep demand, operational gains, and $200M free cash flow guide highlight 2025 outlook.AHCO
Leerink’s Global Healthcare Conference 202526 Dec 2025